Quantbot Technologies’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.29M Buy
81,651
+37,820
+86% +$1.24M 0.09% 335
2025
Q4
$1.64M Buy
+43,831
New +$1.44M 0.05% 516
2025
Q3
Sell
-10,311
Closed -$326K 1904
2025
Q2
$326K Sell
10,311
-18,102
-64% -$582K 0.01% 1111
2025
Q1
$943K Buy
28,413
+22,487
+379% +$806K 0.03% 702
2024
Q4
$204K Buy
5,926
+4,073
+220% +$140K 0.01% 1049
2024
Q3
$74.1K Buy
+1,853
New +$65.1K ﹤0.01% 1220
2024
Q2
Sell
-14,809
Closed -$497K 1644
2024
Q1
$497K Buy
14,809
+8,343
+129% +$268K 0.03% 745
2023
Q4
$209K Buy
+6,466
New +$180K 0.01% 1001
2023
Q3
Sell
-4,718
Closed -$166K 1726
2023
Q2
$166K Buy
+4,718
New +$163K 0.01% 1026
2023
Q1
Sell
-3,417
Closed -$188K 1764
2022
Q4
$188K Sell
3,417
-635
-16% -$34.9K 0.01% 920
2022
Q3
$179K Buy
4,052
+576
+17% +$28.1K 0.01% 923
2022
Q2
$169K Sell
3,476
-6,951
-67% -$313K 0.02% 987
2022
Q1
$507K Buy
10,427
+8,527
+449% +$348K 0.04% 564
2021
Q4
$81K Buy
+1,900
New +$75.7K 0.01% 920

Other funds holding HRMY

Quantbot Technologies's HRMY Position: Q1 2026 in Review

Quantbot Technologies increased its Harmony Biosciences (HRMY) stake by 86% in Q1 2026, buying an estimated $1.24M and bringing the position to 81,651 shares worth $2.29M. The position accounts for 0.09% of the portfolio, ranked #335.

Quantbot Technologies first reported a position in HRMY in Q4 2021 and has held it in 14 quarters since. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Quantbot Technologies held 81,651 shares of Harmony Biosciences worth $2.29M as of Q1 2026.
  • Quantbot Technologies bought 37,820 Harmony Biosciences shares in Q1 2026, an estimated $1.24M.
  • Harmony Biosciences made up 0.09% of Quantbot Technologies's portfolio in Q1 2026, its #335 holding.
  • Quantbot Technologies first reported a position in Harmony Biosciences in Q4 2021 and has held it in 14 quarters since.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.